SOLIQUA 100/33

INSULIN GLARGINE AND LIXISENATIDE · Sanofi-Aventis U.S. LLC

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for SOLIQUA 100/33, covering 2016-11-21 to 2026-03-12. Get the full timeline:

Most recent: FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)